The anti-tumor effects of an adenoviral vaccine expressing 4-1BB ligand in a murine melanoma model

被引：0
|
作者：
Ragonnaud, E. [1 ]
Andersson, A. [1 ]
Jensen, B. A. H. [1 ]
Thomsen, A. R. [1 ]
Holst, P. J. [1 ]
机构：
[1] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark
来源：
IMMUNOLOGY | 2012年 / 137卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：723 / 723
页数：1
相关论文
共 50 条
  • [21] Combined vaccine plus axitinib therapy yields superior anti-tumor efficacy in a murine melanoma model
    Lowe, D. B.
    Bose, A.
    Storkus, W. J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S104 - S104
  • [22] BATF3 DENDRITIC CELLS AND 4-1BB/4-1BB LIGAND AXIS ARE REQUIRED AT THE EFFECTOR PHASE WITHIN THE TUMOR MICROENVIRONMENT FOR ANTI-PD-L1 EFFICACY
    Ziblat, Andrea
    Horton, Brendan
    Higgs, Emily
    Hatogai, Ken
    Gajewski, Thomas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A354 - A354
  • [23] Analysis of 4-1BBL and laminin binding to murine 4-1BB, a member of the tumor necrosis factor receptor superfamily, and comparison with human 4-1BB
    Loo, DT
    Chalupny, NJ
    Bajorath, J
    Shuford, WW
    Mittler, RS
    Aruffo, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (10) : 6448 - 6456
  • [24] Effects of 4-1BB signaling on the biological function of murine dendritic cells
    Kuang, Youlin
    Weng, Xiaodong
    Liu, Xiuheng
    Zhu, Hengchen
    Chen, Zhiyuan
    Chen, Hui
    ONCOLOGY LETTERS, 2012, 3 (02) : 477 - 481
  • [25] Effects of anti-PD-1 and anti-4-1BB antibody treatment on melanoma-specific T cells in a murine model of melanoma
    Robinson, John L.
    Kodumudi, Krithika
    Weber, Amy
    Samaik, Amod
    Pilon-Thomas, Shari
    CANCER RESEARCH, 2013, 73 (08)
  • [26] A BIPARATOPIC ANTI-HER2 ANTIBODY ENABLED WITH CONDITIONAL 4-1BB AGONISM INDUCES POTENT ANTI-TUMOR EFFICACY
    Chen, Liandi
    Huang, Weifeng
    Miao, Xiaoniu
    Peng, Shaogang
    Wang, Chao
    Yan, Yao
    Chou, Chuan-Chu
    Tsun, Andy
    Luo, Yi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1372 - A1372
  • [27] Consequences of 4-1BB-4-1BB Ligand interaction for NK Cell Anti-Tumor Immunity: Oppisite Effects of Seemingly Analogue Molecules in Mice and Men
    Baessler, Tina
    Charton, Jean E.
    Buechele, Corina
    Schmiedel, Benjamin J.
    Gruenebach, Frank
    Krusch, Matthias
    Wacker, Alexander
    Kanz, Lothar
    Salih, Helmut R.
    BLOOD, 2009, 114 (22) : 118 - 118
  • [28] Host Lymphodepletion Enhances the Therapeutic Activity of an Oncolytic Vaccinia Virus Expressing 4-1BB Ligand
    Kim, Hong Sung
    Kim-Schulze, Seunghee
    Kim, Dae Won
    Kaufman, Howard L.
    CANCER RESEARCH, 2009, 69 (21) : 8516 - 8525
  • [29] Preparation of a Plasma-Induced Dendritic Cell Vaccine and its Anti-Tumor Immunity in a Murine Model of Melanoma
    Wang, Xiangni
    Liu, Jinren
    Wang, Xiying
    Lu, Jiajia
    Xu, Guimin
    Cui, Yixin
    He, Zhirou
    Xu, Yulin
    Shi, Xingmin
    Zhang, Guanjun
    ADVANCED THERAPEUTICS, 2024, 7 (10)
  • [30] A novel form of 4-1BB ligand has better efficacy than agonistic 4-1BB antibody as well as TLR agonists in a peptide based cancer vaccine
    Sharma, Rajesh K.
    Elpek, Kutlu G.
    Yolcu, Esma S.
    Schabowsky, Rich-Henry
    Zhao, Hong
    Bandura-Morgan, Laura L.
    Shirwan, Haval
    JOURNAL OF IMMUNOLOGY, 2009, 182
12345